FDA inspection
Cipla Limited: FDA inspection ending Jun 21, 2024
FDA inspection 1240813 · Voluntary Action Indicated (VAI) · Salcette
Key facts
| Inspection ID | 1240813 |
|---|---|
| Firm | Cipla Limited |
| FEI number | 3004081307 |
| Address | 1 2 3 L - 147 A L - 138 L - 150 S - 116 To L - 147, I D C Verna Industrial Road; L147 To S - 112 |
| City | Salcette |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Jun 21, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data